HUP0000397A2 - Minimális szisztémás hatású glukokortikoidok alkalmazása ízületi gyulladás kezelésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Minimális szisztémás hatású glukokortikoidok alkalmazása ízületi gyulladás kezelésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP0000397A2
HUP0000397A2 HU0000397A HUP0000397A HUP0000397A2 HU P0000397 A2 HUP0000397 A2 HU P0000397A2 HU 0000397 A HU0000397 A HU 0000397A HU P0000397 A HUP0000397 A HU P0000397A HU P0000397 A2 HUP0000397 A2 HU P0000397A2
Authority
HU
Hungary
Prior art keywords
treatment
pasessing
glucocorticoid
substances
pharmaceutical composition
Prior art date
Application number
HU0000397A
Other languages
English (en)
Inventor
Roger Hällgren
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HUP0000397A2 publication Critical patent/HUP0000397A2/hu
Publication of HUP0000397A3 publication Critical patent/HUP0000397A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya minimális szisztémás hatású glukokortikoidokalkalmazása orális vagy rektális beadásra szánt, nem helyi használatraszánt, ízületi gyulladás kezelésére szolgáló, gyógyszerkészítményekelőállítására. Ó
HU0000397A 1996-12-20 1997-12-16 The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation HUP0000397A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604751A SE9604751D0 (sv) 1996-12-20 1996-12-20 New therapy
PCT/SE1997/002124 WO1998027987A1 (en) 1996-12-20 1997-12-16 New treatment for joint inflammation

Publications (2)

Publication Number Publication Date
HUP0000397A2 true HUP0000397A2 (hu) 2000-10-28
HUP0000397A3 HUP0000397A3 (en) 2001-01-29

Family

ID=20405107

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000397A HUP0000397A3 (en) 1996-12-20 1997-12-16 The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation

Country Status (20)

Country Link
US (1) US6432937B1 (hu)
EP (1) EP0957922A1 (hu)
JP (1) JP2001507024A (hu)
KR (1) KR20000069594A (hu)
AU (1) AU5502598A (hu)
BR (1) BR9713975A (hu)
CA (1) CA2274769A1 (hu)
CZ (1) CZ219399A3 (hu)
EE (1) EE9900258A (hu)
HU (1) HUP0000397A3 (hu)
ID (1) ID21763A (hu)
IL (1) IL130485A0 (hu)
IS (1) IS5056A (hu)
NO (1) NO993066L (hu)
NZ (1) NZ336025A (hu)
PL (1) PL334012A1 (hu)
SE (1) SE9604751D0 (hu)
SK (1) SK82699A3 (hu)
TR (1) TR199901413T2 (hu)
WO (1) WO1998027987A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2101819T3 (da) 2006-11-20 2013-04-29 Harvard College Fremgangsmåder, sammensætninger og kits til behandling af smerte og pruritis
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
EP3485881B1 (en) 2009-07-10 2024-03-13 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
BR112013020874A2 (pt) 2011-02-18 2019-05-21 Endo Pharmaceuticals Inc. composto, regime, método para a preparação do referido composto, e, uso de um composto
JP6495654B2 (ja) 2011-10-24 2019-04-03 アサナ バイオサイエンシズ，リミティド ライアビリティ カンパニー シクロヘキシルアミン類
AU2014365823B2 (en) 2013-12-16 2019-05-02 Abs Development 1, Inc. P2X3 and/or P2X2/3 compounds and methods
CA2994545A1 (en) 2015-08-03 2017-02-09 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
JP2016193937A (ja) * 2016-08-09 2016-11-17 株式会社エヌ・エル・エー 関節痛緩和組成物および機能性食品、並びに発酵ショウガ及びその製造方法
WO2018064135A1 (en) 2016-09-30 2018-04-05 Asana Biosciences, Llc P2x3 and/or p2x2/3 compounds and methods
KR20210145164A (ko) 2019-03-11 2021-12-01 녹시온 테라퓨틱스 인코포레이티드 에스테르 치환된 이온 채널 차단제 및 사용 방법
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2022525856A (ja) 2019-03-11 2022-05-20 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
CA3129117A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
IL292505A (en) 2019-11-06 2022-06-01 Nocion Therapeutics Inc Charged ion channel blockers and methods of use
EP4054586A4 (en) 2019-11-06 2023-11-22 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
AU2021236130A1 (en) 2020-03-11 2022-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
CA2140660A1 (en) * 1993-06-13 1994-12-22 Uwe R. Juergens Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
BR9713975A (pt) 2000-04-11
SK82699A3 (en) 2000-02-14
AU5502598A (en) 1998-07-17
IL130485A0 (en) 2000-06-01
TR199901413T2 (xx) 1999-08-23
JP2001507024A (ja) 2001-05-29
PL334012A1 (en) 2000-01-31
SE9604751D0 (sv) 1996-12-20
NO993066D0 (no) 1999-06-21
WO1998027987A1 (en) 1998-07-02
IS5056A (is) 1999-05-27
US6432937B1 (en) 2002-08-13
CA2274769A1 (en) 1998-07-02
NO993066L (no) 1999-06-21
KR20000069594A (ko) 2000-11-25
HUP0000397A3 (en) 2001-01-29
EE9900258A (et) 1999-12-15
EP0957922A1 (en) 1999-11-24
CZ219399A3 (cs) 1999-09-15
ID21763A (id) 1999-07-22
NZ336025A (en) 2001-02-23

Similar Documents

Publication Publication Date Title
HUP0000397A2 (hu) Minimális szisztémás hatású glukokortikoidok alkalmazása ízületi gyulladás kezelésére szolgáló gyógyszerkészítmények előállítására
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
ATE238773T1 (de) Arzneimittel für die kombination piperidinoalkanol-dekongestivum
ES2187201T3 (es) Empleo de esteroles y de esterolesteres a nanoescala.
ES8801785A1 (es) Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.
AU7031500A (en) Therapeutic quinazoline compounds
NO991405L (no) Belagt partikkelformulering
NO990845L (no) Anvendelse av en kombinasjon av amoksicillin og klavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse
HUP9903931A2 (hu) Indolopirrolokarbazolok citotoxikus aminocukor- és más rokon jellegű cukorszármazékai
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
SI0929565T1 (en) Nitrate esters of corticoid compounds and pharmaceutical applications thereof
HK1000283A1 (en) New derivatives of non-steroidal anti-inflammatory anaggesic and/or antipyretic substances their use and pharmaceutical formulations containg them
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
DE3860201D1 (de) Entzuendungshemmende agentien.
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
DE69937301D1 (de) Aminosterolderivate und ihre verwendungen
GB9923078D0 (en) Sapogenin derivatives and their use
ATE192435T1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
DE69512715T2 (de) Aconitin ähnliche verbindung und antipyretisches, analgetisches und entzündungshemmendes mittel
AU580890B2 (en) P-acylaminobenzamides